CSF2 and tuberculosis: In conclusion, integrating GM-CSF with DNA vaccines targeting M. tuberculosis, particularly in conjunction with BCG priming, has shown significant promise in enhancing immune responses and protective efficacy, suggesting a strategic avenue for tuberculosis management.